Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Pieter Jelle Visser, MD, PhD from Maastricht University and VU University Medical School, Amsterdam, Netherlands gives us his opinion on the importance of targeting amyloid pathology in preventing the development of dementia. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.